<DOC>
	<DOCNO>NCT03000387</DOCNO>
	<brief_summary>Medications smoke cessation currently effective help minority smoker quit . Drug development slow expensive , much interest optimize effectiveness exist treatment medication . Current standard dos nicotine replacement therapy ( NRT ) effective many smoker many case provide less nicotine compare smoker smoke usual number cigarette . The propose study test personalize dose nicotine patch ( 84mg ) improve quit success respond standard dose NRT ( 21mg ) .</brief_summary>
	<brief_title>Personalized Dosing Nicotine Replacement ( NRT Effect )</brief_title>
	<detailed_description>A total 500 smoker enrol two smoke cessation clinic participate study . After 2 week usual treatment 21mg patch , participant fail quit smoking randomize receive either escalate dos active nicotine patch , placebo patch , 10 week . Those stop smoking first 2 week usual treatment continue 21mg patch treatment 10 week additional comparison group . In addition medication , participant group receive brief behavioral counselling . Subjects return clinic week 26 52 ass whether still abstinent smoke self-reports non-smoking confirm use breath carbon monoxide measure urine test nicotine by-product ( cotinine ) level . The goal propose study optimize current gold standard smoke cessation treatment ( nicotine patch plus brief counseling ) order increase quit rate . Evidence support effectiveness personalize dos NRT could change current practice wide variety healthcare setting . Given strong link smoking cancer , evidence quit smoke age diminishes risk , even small increase absolute quit rate substantial population-level impact reduce incidence smoking-related cancer , reduce mortality rate associate healthcare cost .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<criteria>1 . Daily tobacco smoker â‰¥10 cigarettes per day 2 . Aged 18 75 year old 3 . Intending quit smoking within next 30 day 1 . At least weekly use tobacco product cigarettes unwilling stop use duration study 2 . Breast feeding , pregnancy use reliable form birth control 3 . Any generalized skin disorder preclude use patch 4 . Currently use NRT smoke cessation pharmacotherapy 5 . Any known hypersensitivity allergy component comprise nicotine patch 6 . Current active substance dependence ( exclude caffeine ) compromise study compliance 7 . Current unstable psychiatric condition would compromise study compliance 8 . Diagnosis terminal illness 9 . Current regular use ecigarettes , vaping device , willing stop duration study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Nicotine Replacement Therapy</keyword>
	<keyword>Smoking Cessation</keyword>
	<keyword>Randomized Clinical Trial</keyword>
	<keyword>Nicotine Patch</keyword>
	<keyword>Abstinence</keyword>
	<keyword>Placebo</keyword>
	<keyword>Double blind</keyword>
</DOC>